Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 323.00 billion. The enterprise value is 317.32 billion.

Market Cap	323.00B
Enterprise Value	317.32B

Important Dates

The last earnings date was Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Nov 6, 2024

Share Statistics

Current Share Class	124.89M
Shares Outstanding	n/a
Shares Change (YoY)	-0.66%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	41.84M

Valuation Ratios

The trailing PE ratio is 35.09 and the forward PE ratio is 30.46.

PE Ratio	35.09
Forward PE	30.46
PS Ratio	6.95
PB Ratio	8.52
P/TBV Ratio	8.63
P/FCF Ratio	38.48
P/OCF Ratio	27.91
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.02, with an EV/FCF ratio of 37.81.

EV / Earnings	34.48
EV / Sales	6.83
EV / EBITDA	25.02
EV / EBIT	28.23
EV / FCF	37.81

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.01.

Current Ratio	2.85
Quick Ratio	1.80
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	0.06
Interest Coverage	54.23

Financial Efficiency

Return on equity (ROE) is 25.02% and return on invested capital (ROIC) is 18.88%.

Return on Equity (ROE)	25.02%
Return on Assets (ROA)	14.56%
Return on Invested Capital (ROIC)	18.88%
Return on Capital Employed (ROCE)	27.97%
Revenue Per Employee	5.76M
Profits Per Employee	1.14M
Employee Count	8,073
Asset Turnover	0.96
Inventory Turnover	1.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.91%
50-Day Moving Average	2,598.16
200-Day Moving Average	2,865.83
Relative Strength Index (RSI)	49.29
Average Volume (20 Days)	2,623

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 46.48 billion and earned 9.20 billion in profits. Earnings per share was 73.53.

Revenue	46.48B
Gross Profit	35.77B
Operating Income	11.24B
Pretax Income	11.89B
Net Income	9.20B
EBITDA	12.68B
EBIT	11.24B
Earnings Per Share (EPS)	73.53

Full Income Statement

Balance Sheet

The company has 6.15 billion in cash and 474.20 million in debt, giving a net cash position of 5.68 billion.

Cash & Cash Equivalents	6.15B
Total Debt	474.20M
Net Cash	5.68B
Net Cash Per Share	n/a
Equity (Book Value)	37.90B
Book Value Per Share	303.53
Working Capital	18.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.57 billion and capital expenditures -3.18 billion, giving a free cash flow of 8.39 billion.

Operating Cash Flow	11.57B
Capital Expenditures	-3.18B
Free Cash Flow	8.39B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.96%, with operating and profit margins of 24.19% and 19.80%.

Gross Margin	76.96%
Operating Margin	24.19%
Pretax Margin	25.58%
Profit Margin	19.80%
EBITDA Margin	27.29%
EBIT Margin	24.19%
FCF Margin	18.06%

Dividends & Yields

This stock pays an annual dividend of 54.00, which amounts to a dividend yield of 2.13%.

Dividend Per Share	54.00
Dividend Yield	2.13%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	37.96%
Buyback Yield	0.66%
Shareholder Yield	2.79%
Earnings Yield	2.85%
FCF Yield	2.60%

Dividend Details

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a